Viking Therapeutics, Inc.
USD29.33
+0.04 (+0.14%)
CEO
Brian Lian
IPO Date
2015-04-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.13
Prev. Close
$29.29
Day Low
$29.06
Day High
$29.80
52W Low
$22.96
52W High
$43.15
Market Cap
$3.41B
Volume
1.46M
| 180,000 |
| $31.76 |
| 26 Jan 2026 | Aubuchon Neil William | — | Disposed | 0 | $0.00 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | A-Award | Acquired | 41,000 | $0.00 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | A-Award | Acquired | 32,049 | $0.00 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 31,961 | $32.30 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 13,900 | $33.38 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 10,300 | $34.24 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 1,500 | $32.09 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | A-Award | Acquired | 91,000 | $35.42 |